FectoVIR®-AAV, the new tool to enhance recombinant AAV production for gene therapy

Ever-increasing demand for clinical and commercial-scale recombinant adeno-associated viral (rAAV) vector manufacturing has brought into sharp focus the need for new technological innovation to drive the requisite bioprocess productivity and efficiency gains.    

In this webinar, Viralgen - a CDMO born as a joint venture between Askbio and Columbus Venture Partners, and recently acquired by Bayer - will discuss its approach to driving the industrialization of rAAV vector production, and present recent data obtained with the FectoVIR®-AAV transfection reagent for the production of rAAV in its Pro10™ cell line.

Attendees will learn:

• How to optimize AAV productions based on improved transfection tools.
• How to improve transfection reproducilbility and rAAv production at different production scales.

Mathieu Porte

Project Leader at Polyplus-transfection

Mathieu Porte is Bioproduction R&D Manager at Polyplus-transfection®. After obtaining his Biotechnology Engineering Degree from the renowned European School ESBS (Strasbourg, France), he worked as Research Assistant at New England Biolabs and UCSF. He joined Polyplus-transfection® in 2009. During 10 years in the Bioproduction R&D group, he carried out the development of several innovative transfection solutions dedicated to biomanufacturing.

Elisa Da Silva Ferrada

USP Process Development Lead Scientist, Viralgen Vector Core (VVC)

Valerie Lang

Production Manger, Viralgen VC

Watch now

SPEAKERS

Mathieu Porte

Project Leader at Polyplus-transfection

Elisa Da Silva Ferrada

USP Process Development Lead Scientist, Viralgen Vector Core (VVC)

Valerie Lang

Production Manger, Viralgen VC

You might also like

Process in the product: a new analytical tool for AAV production optimization and monitoring

Blaž Bakalar, Ivana Petrović Koshmak

19 November

Watch

Increasing efficiency in AAV-based gene therapy production: platform optimization with multiserotype AAV affinity capture

Nicolas Laroudie, Tiago Albano

27 March

Watch

Considerations in leveraging the Universal AAV Standard for dPCR to assess AAV genomes quantity and quality

Andrzej Noyszewski, Alex Deiulio

10 September

Watch

Mastering AAV production: best practices For small- to large-scale manufacturing success and reduced development time

Emily Jackson-Holmes

21 May

Watch

Accelerating AAV production: optimizing compound identification and process parameters

Keara Sutherland, Jean-Marc Guedon

20 November

Watch